Epigeneres, in collaboration with Tzar Labs, has developed a groundbreaking diagnostic tool for early cancer detection. This tool represents a significant advancement in the field of oncology diagnostics. Here are the key aspects of Epigeneres' offerings and approach: Innovative Cancer Detection: Epigeneres has co-developed a novel diagnostic tool that can predict the presence of cancer at asymptomatic early stages with very high sensitivity. HrC Test: Their primary product, the HrC test, is a single blood test capable of detecting all types of cancers, including solid, hematological, and soft tissue sarcomas. Early Detection and Accuracy: The HrC test can detect cancer prior to tumor formation, at pre-stage 1 (stage 0) and stage 1. Initial studies with 1,000 patients have shown an accuracy rate of over 99%. Prognostic Capability: Unique among cancer tests, the HrC test is also a prognostic tool. It can determine the risk that a patient may develop cancer within the next 12 months. Mission Statement: Dr. V. K. Tripathi, the founder of Epigeneres, emphasizes that "The only real cure for cancer is early detection." This statement underlines the company's commitment to early cancer detection and prevention. Epigeneres stands out in the medical field for its innovative approach to early cancer detection and prognosis, aiming to significantly impact cancer treatment outcomes through their advanced diagnostic technology.
NovaGenere, nCurcu
HrC Test (Early Cancer Detection Test)
Epigeneres Biotech
Epigeneres Biotech
Epigeneres is revolutionizing cancer detection and health management through advanced diagnostics and nutrigenomic solutions, focusing on stem cell research and nutritional genomics.
101, 1st Floor, Todi Building, Mathuradas Mills Compound, Senapati Bapat Marg, Lower Parel (West), Mumbai 400013
April 25, 2012
Mumbai, Maharashtra
At Mocero Health, we are committed to maintaining the trust and confidence of our visitors and users. This Index Data Usage Notice explains how we collect, use, and share data related to the various indices and aggregated metrics presented on our site. Index data on Mocero Health is generated through a combination of proprietary algorithms, user interactions, and publicly available health data. This may include, but is not limited to, health condition prevalence rates, treatment effectiveness scores, healthcare facility ratings, and user search trends. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using Mocero Health, you acknowledge and agree to the collection, use, and sharing of index data as described in this notice.
The information provided on this website is intended for general and educational purposes only. We reserve the right to modify this content policy at any time. Changes will be effective immediately upon posting the revised policy. Your continued use of the platform after any changes signifies your agreement to the new terms. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using this site, you acknowledge and agree that you have read and understood this Content Disclaimer.
Stay up-to-date with news about health-tech startups, compiled and presented in a centralized platform.
Dive into the latest insights and trends with our blogs section. Each post is carefully curated to provide
you with the most valuable and actionable content, ensuring you stay informed.
Showing 1 blogs